BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28693214)

  • 1. Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.
    Thuwajit C; Thuwajit P; Jamjantra P; Pairojkul C; Wongkham S; Bhudhisawasdi V; Ono J; Ohta S; Fujimoto K; Izuhara K
    Oncol Lett; 2017 Jul; 14(1):623-634. PubMed ID: 28693214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
    Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
    Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
    Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma.
    Truong SDA; Tummanatsakun D; Proungvitaya T; Limpaiboon T; Wongwattanakul M; Chua-On D; Roytrakul S; Proungvitaya S
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
    Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
    Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
    Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.
    Sanmai S; Proungvitaya T; Limpaiboon T; Chua-On D; Seubwai W; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sangkhamanon S; Proungvitaya S
    Oncol Lett; 2019 Jun; 17(6):5275-5282. PubMed ID: 31186744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma.
    Chanakankun R; Proungvitaya T; Chua-On D; Limpaiboon T; Roytrakul S; Jusakul A; Titapun A; Jarearnrat A; Proungvitaya S
    Oncol Lett; 2020 Jan; 19(1):930-942. PubMed ID: 31897206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
    Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
    J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma.
    Utispan K; Sonongbua J; Thuwajit P; Chau-In S; Pairojkul C; Wongkham S; Thuwajit C
    Int J Oncol; 2012 Sep; 41(3):1110-8. PubMed ID: 22735632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-25 is associated with progression and poor prognosis of cholangiocarcinoma.
    Liu H; Ma L; Wang J
    Exp Ther Med; 2019 Oct; 18(4):2687-2694. PubMed ID: 31555370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.
    You MS; Lee SH; Kang J; Choi YH; Choi JH; Shin BS; Huh G; Paik WH; Ryu JK; Kim YT; Jang DK; Lee JK
    Gut Liver; 2019 May; 13(3):373-379. PubMed ID: 30600674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.